首页> 外文期刊>Radiation oncology >Assessing cumulative dose distributions in combined radiotherapy for cervical cancer using deformable image registration with pre-imaging preparations
【24h】

Assessing cumulative dose distributions in combined radiotherapy for cervical cancer using deformable image registration with pre-imaging preparations

机译:使用可变形图像配准和预成像制剂评估宫颈癌联合放疗中的累积剂量分布

获取原文
           

摘要

Background The purpose of the study was to evaluate the feasibility of deformable image registration (DIR) in assessing cumulative dose distributions of the combination of external beam radiotherapy (EBRT) and fractionated intracavitary brachytherapy (ICBT) for cervical cancer. Materials and methods Three-dimensional image data sets of five consecutive patients were used. The treatment plan consisted of whole pelvic EBRT (total dose: 45 Gy in 25 fractions) combined with computed tomography (CT)-based high-dose rate ICBT (≥24 Gy in 4 fractions to the high risk clinical target volume (HR-CTV)). Organs at risk and HR-CTV were contoured on each CT images and dose-volume parameters were acquired. Pre-imaging preparations were performed prior to each ICBT to minimize the uncertainty of the organ position. Physical doses of each treatment were converted to biologically equivalent doses in 2 Gy daily fractions by the linear quadratic model. Three-dimensional dose distributions of each treatment were accumulated on CT images of the first ICBT using DIR with commercially available image registration software (MIM Maestro?). To compare with DIR, 3D dose distributions were fused by rigid registration based on bony structure matching. To evaluate the accuracy of DIR, the Dice similarity coefficient (DSC) was measured between deformed contours and initial contours. Results The cumulative dose distributions were successfully illustrated on the CT images using DIR. Mean DSCs of the HR-CTV, rectum, and bladder were 0.46, 0.62 and 0.69, respectively, with rigid registration; and 0.78, 0.76, and 0.87, respectively, with DIR (p <0.05). The mean DSCs derived from our DIR procedure were comparable to those of previous reports describing the quality of DIR algorithms in the pelvic region. DVH parameters derived from the 2 methods showed no significant difference. Conclusions Our results suggest that DIR-based dose accumulation may be acceptable for assessing cumulative dose distributions to assess doses to the tumor and organs at risk in combined radiotherapy for cervical cancer under pre-imaging preparations.
机译:背景技术本研究的目的是评估可变形图像配准(DIR)在评估子宫颈癌外照射放疗(EBRT)和腔内近距离放射治疗(ICBT)联合使用的累积剂量分布中的可行性。材料和方法使用5位连续患者的三维图像数据集。该治疗计划包括整个盆腔EBRT(总剂量:每25步45 Gy)与基于计算机断层扫描(CT)的高剂量率ICBT(4步≥24 Gy达到高风险临床目标量(HR-CTV) ))。在每张CT图像上勾勒出有风险的器官和HR-CTV的轮廓,并获取剂量-体积参数。在每次ICBT之前进行预成像准备,以最大程度地减少器官位置的不确定性。通过线性二次模型,将每种处理的物理剂量转换为每天2 Gy的生物等效剂量。使用DIR和可商购的图像配准软件(MIM Maestro?),将每种处理的三维剂量分布累积在第一个ICBT的CT图像上。为了与DIR进行比较,基于骨结构匹配通过刚性配准融合了3D剂量分布。为了评估DIR的准确性,在变形轮廓和初始轮廓之间测量了Dice相似系数(DSC)。结果使用DIR在CT图像上成功显示了累积剂量分布。 HR-CTV,直肠和膀胱的平均DSC分别为0.46、0.62和0.69,且具有刚性配准。 DIR分别为0.78、0.76和0.87(p <0.05)。从我们的DIR程序得出的平均DSC与以前描述骨盆区域DIR算法质量的报告相当。从这两种方法得出的DVH参数没有显着差异。结论我们的结果表明,基于DIR的剂量累积可用于评估累积剂量分布,以评估在预成像准备下的宫颈癌联合放疗中对处于危险中的肿瘤和器官的剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号